| 1 |
32457377 | Discovery of a new sialic acid binding region that regulates Siglec-7. | 2020 May 26 |
1 |
| 2 |
25230315 | Role of Siglec-7 in apoptosis in human platelets. | 2014 |
2 |
| 3 |
23173866 | Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome. | 2013 Feb |
1 |
| 4 |
20663960 | Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells. | 2010 Nov |
1 |
| 5 |
19608407 | Gangliosides in cell recognition and membrane protein regulation. | 2009 Oct |
1 |
| 6 |
16623661 | The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design. | 2006 Jul 15 |
1 |
| 7 |
16857734 | Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression. | 2006 Oct |
1 |
| 8 |
12639556 | Ganglioside binding pattern of CD33-related siglecs. | 2003 Feb 24 |
1 |
| 9 |
12778482 | Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. | 2003 Jun |
1 |
| 10 |
11389909 | Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression. | 2001 Jun 1 |
1 |
| 11 |
11522302 | Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression. | 2001 Aug 24 |
1 |